SUMMARYPancreatic islet-like clusters differentiated from induced pluripotent or embryonic stem cells (SC-islets) are a promising cellular therapy for type 1 diabetes. A standardized and easily applied protocol to assess the quality of SC-islet differentiations would be a valuable resource to ensure consistency across cell preparations. We present a workflow for processing SC-islet clusters to single cells and for intracellular flow cytometry stains using commercially available reagents and antibodies to distinguish cell types generated during a 7-stage differentiation protocol.